Opple Lighting Co., Ltd.

Suzhou Opple Lighting Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd.

Yu Mao

Guangxin Xia

Yanjun Liu

Songjing Jiang

Qian Wang

Liwei Zhao

Hui Ge

Xuemei Liao

Zhixiong Xiang

Yinglong Sun

Yanan Han

Chen Shi

Guoyong Huo

Xiong Zhai

Jing Jing Zhang

Shitao Deng

Di Li

Shuangzeng Li

Yaohai Wang

Lingjun Duan

Xin Dai

Hongjian Zuo

Guangsheng Wu

Xiaoshan Li

Ji Ma

The present disclosure provides a magnetic absorbing guide rail component and a lighting system. The magnetic absorbing guide rail component includes a strip rail, an insulating member, a pair of strip electrodes, a magnetic device, and a magnet. This disclosure adopts an aluminum profile as a strip rail, the strip rail has a relatively small width, and two strip electrodes are embedded in the insulating member.

Magnetic absorbing guide rail component and lighting system

The present disclosure discloses a magnetically-adsorbed conductive track, a magnetically-adsorbed conductive track system and an electrical system in the field of lighting technology. The electrical system includes: at least two magnetically-adsorbed conductive tracks, at least one electrical apparatus and at least one adapter; the adapter cascades at least two magnetically-adsorbed conductive tracks. The magnetically-adsorbed conductive track includes: a main body portion including an adsorbing wall and a mounting wall; and an insulating portion and a magnetic element arranged in the main body portion; the insulating portion includes: a second space in communication with the adsorbing wall, and a first space which accommodates a conductive portion and is in communication with the second space; an elastic conductive terminal of the electrical apparatus and a collocating portion are jointly collocated into the second space of the magnetically-adsorbed conductive track.

Magnetically-adsorbed conductive track, adapter, electrical apparatus, and electrical system

The present disclosure discloses a lamp including a light source module, a first magnetic attraction conductive member, a magnetic attraction power interface member and a first sleeve, wherein the light source module includes a substrate and a light emitter connected to a side of the substrate; the first magnetic attraction conductive member is electrically connected to an end of the light source module; the magnetic attraction power interface member is configured to be electrically connected to a power line, and magnetically attracted and electrically attached to the first magnetic attraction conductive member; the first sleeve is configured to be installed to an installation basic structural member, and has a threading hole for threading the power line and an accommodation cavity, the magnetic attraction power interface member and the first magnetic attraction conductive member are both installed within the accommodation cavity.

Lamp

The present disclosure discloses a lighting fixture, including: a base, where the base is provided with a driving power supply; a lighting column, where the lighting column includes a column body and a conductive track, one end of the column body is installed on the base, the column body is provided with a sunk groove extending along a length direction of the column body, the conductive track is installed in the sunk groove, and the conductive track is electrically connected with the driving power supply; a sliding assembly, where the sliding assembly includes a sliding body and a conductive portion; and a lighting cap assembly, wherein the lighting cap assembly includes a housing and a light source, the light source is installed in the housing, the housing is connected with the sliding body, and the light source is connected with the conductive portion.

Lighting fixture

The present disclosure discloses a light emitting assembly and a lamp, the light emitting assembly includes a base portion, a conductive portion, a light source and a transparent insulating layer, the base portion is a rigid structure; the conductive portion is arranged on a surface of the base portion, and is insulated from the base portion; the light source is installed on the surface of the base portion where the conductive portion is located, and is electrically connected to the conductive portion; the transparent insulating layer covers the conductive portion and the light source.

Light emitting assembly and lamp

The present invention discloses a substituted pyridine compound represented by formula I, and a pharmaceutically acceptable salt, stereoisomer and tautomer thereof. The compounds of the present invention are useful in the treatment of cancers. 

Substituted pyrimidines as cyclin-dependent kinase inhibitors

Disclosed are a nitrogenous heterocyclic compound, intermediates, a preparation method, a composition and use thereof. The nitrogenous heterocyclic compound in the present invention is as shown in formula I. The compound has a high inhibitory activity towards ErbB2 tyrosine kinase and a relatively good inhibitory activity towards human breast cancer BT-474 and human gastric cancer cell NCI-N87 which express ErbB2 at a high level, and at the same time has a relatively weak inhibitory activity towards EGFR kinase. Namely, the compound is a highly selective small-molecule inhibitor targeted at ErbB2, and hence it has a high degree of safety, and can effectively enlarge the safety window in the process of taking the drug. 

Nitrogenous heterocyclic compound, preparation method, intermediate, composition and use

The present invention discloses a nitrogen-containing fused heterocyclic compound, as well as a preparation method, intermediate, composition and application thereof. The nitrogen-containing fused heterocyclic compound of the present invention as represented by formula (I), as well as the pharmaceutically acceptable salt, enantiomer, diastereomer, tautomer, solvate, metabolite or drug precursor thereof, exhibit a high selectivity and a high inhibitory activity with respect to CDK4 and CDK6 at a molecular level, an excellent inhibitory activity with respect to breast cancer cells at a cellular level, and significant inhibition of tumor cell proliferation associated with cyclin-dependent kinase activity at an animal level. The invention also exhibits a good stability with respect to human or mouse liver microsomes without significant inhibition of metabolic enzymes, good in vivo absorption in mice and rats, a high bioavailability and good druggability.

Growing community of inventors

Shanghai, China

Yu Mao